Dose-dense adjuvant doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Heart Diseases
  • Stroke Volume

abstract

  • Dose-dense AC with or without concurrent bevacizumab is not associated with frequent acute or short-term declines in LVEF.

publication date

  • December 20, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3664032

Digital Object Identifier (DOI)

  • 10.1200/JCO.2008.20.2952

PubMed ID

  • 19901120

Additional Document Info

start page

  • 6117

end page

  • 23

volume

  • 27

number

  • 36